Search Share Prices
GSK Shares - GlaxoSmithKline injects US$250mln into US biotech Vir in coronavirus treatment collaboration
Vir's has two candidates that have proved highly potent in neutralising SARS-CoV-2 in live virus-cellular assays GlaxoSmithKline specialises in vaccines and viruses such as HIV GlaxoSmithKline PLC ...
FTSE 100 sashaying sideways at higher levels as traders wait for strong US open
BP is off 0.9% and Shell 0.6%. Also underperforming the index is drugs leviathan GlaxoSmtihkline PLC (LON:GSK), which today announced a collaboration with Vir Biotechnology to fund coronavirus ...
Broker Forecast - DZ Bank issues a broker note on GlaxoSmithKline PLC
StockMarketWire.com - DZ Bank today reaffirms its buy investment rating on GlaxoSmithKline PLC [LON:GSK] and cut its price target to 1900p (from 2000p).
Broker Forecast - Oddo issues a broker note on GlaxoSmithKline PLC
StockMarketWire.com - Oddo today reaffirms its neutral investment rating on GlaxoSmithKline PLC [LON:GSK] and cut its price target to 1530p (from 1830p).
Chronic Kidney Disease Drugs Market Expected to Grow at a CAGR of 4.5% by 2027|AstraZeneca, Amgen Inc., Pfizer Inc.
Research Nester released a report titled "Chronic Kidney Disease Drugs Market: Global Demand Analysis & Opportunity Outlook 2027" which delivers detailed overview of the global chronic kidney disease ...